TG THERAPEUTICS, INC.
TGTX—
TG THERAPEUTICS, INC.TGTX$0.00
+$0.00(+NaN%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
—
P/E ratio
—
EPS (diluted)
$2.77
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$616.29M
Net income
$447.18M
Net margin
72.6%
Gross margin
—
Dividends & financials
TG THERAPEUTICS, INC. (TGTX) reported revenue of $616.29M and net income of $447.18M, or $2.77 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.